3-(5-Chlorobenzofuran-2-yl)-1H-pyrazole, 95.0%, 250mg

3-Bromo-5-methyl-1H-pyrazole, 95.0%, 10g

Ethyl 2,4-dimethylthiazole-5-carboxylate, 97.0%, 100g

[2-(1H-imidazol-1-yl)phenyl]amine hydrochloride, 95.0%, 1g

1-(3-Methoxy-4-nitrophenyl)-4-methylpiperazine, 95.0%, 10g

1-Methyl-3-(thiophen-2-yl)piperazine, 95%, 250mg

(2-(Hydroxymethyl)-4-(trifluoromethyl)phenyl)boronic acid, 98%, 1g

GC capillary column ROTI®Cap-FFAP, 50 m, 0.32 mm, 0.50 µm, 1 Piece(s)

[1-(4-bromophenyl)cyclopentyl]methanamine, 95%, 100mg

Ethyl 4-bromothiazole-2-carboxylate, 95.0%, 1g

Tert-butyl 8-azaspiro[bicyclo[3.2.1]octane-3,2'-oxirane]-8-carboxylate, 95%, 100mg

(R)-(-)-Tetrahydrofurfurylamine>98.0%(GC)(T)5g

4-(3-Nitrophenyl)-3-thiosemicarbazide, 250mg